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In the earlier days of sulfonamide therapy, the results of the
treatment of bone infections were disappointing because
sulfanilamide and sulfapyridine were the drugs in general
use, and these have relatively little effect upon staphylo-
coccic infections. The introduction of sulfathiazole and
sulfadiazine has altered the picture, because the growth of
both streptococci and staphylococci is inhibited by con-
centrations of these drugs, which may be maintained in the
blood stream with relative safety.
Bacteria which are free in the blood stream are espe-
cially vulnerable to the drug, when it is administered
systemically. Organisms in the tissues, in areas of inflam-
mation, and in abscess cavities are less vulnerable to the
sulfonamides for several reasons:
1. Actual contact of the drug with the bacteria is neces-
sary, and the effectiveness of the drug varies directly
with its concentration. The concentration in the tissues
is less than that present in the blood stream (about one-
half), and it is probable that many bacteria in inflamed
areas are so well walled off from the blood stream that
very little of the drug reaches them.
2. The action of the sulfonamides is inhibited by products
of tissue destruction (peptones). The drugs are less
effective if large numbers of bacteria are present.
3. In low concentrations, the drugs do not kill bacteria,
but merely inhibit their growth, and they are then
destroyed by the defense mechanisms of the host.
However, inhibited but still living organisms may
remain in the tissues, escape destruction, and later
become active.
It is thus evident that the sulfonamides in the blood
stream cannot exert their maximum effect upon bacteria
in localized areas of disease; this is especially true in
chronic osteomyelitis where some of the bacteria may be
thoroughly isolated from the blood stream, and located in
areas where the leukocytes cannot reach and destroy
them, even if their growth is inhibited. On the other
hand, we now have sufficient clinical evidence to war-
rant the conclusion that the systemic administration of
sulfadiazine, and especially of sulfathiazole, to patients
with acute osteomyelitis or an acute exacerbation of
chronic osteomyelitis, usually has a beneficial effect, not
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only upon the septicaemia, but also upon the local
disease.
There is, however, considerable difference of opinion as
to how much reliance is to be placed upon the drug in the
treatment of the local disease. Some surgeons (Hoyt, Davis,
and Van Buren) believe that most cases of acute osteo-
myelitis can be cured by the systemic administration of
sulfathiazole, and that operation is rarely necessary. Others,
of whom the author is one, believe that sulfathiazole is a
valuable adjunct in the treatment of this disease, but that
the focus in the bone should be drained and the limb
immobilized as soon after the onset of the disease as the
patient can stand the relatively minor operative procedure.
Failure to do this may result in increased destruction of
bone.
In chronic osteomyelitis, continuous administration of
the drug over a long period will lessen the amount of
discharge, but it will not cure the disease, because it cannot
sterilize dead bone or cavities with necrotic contents and
rigid walls. Here the problem is largely a mechanical one
of removing the dead and infected bone, of eliminating the
dead spaces, and of covering the remaining living bone
with soft tissue that has an adequate blood supply to permit
healing. In the Orr treatment, the operation was performed
in an effort to obtain these results, the wound was packed
loosely with vaseline gauze, left wide open, and permitted
to heal by granulation. For several years the author has
been partially closing such wounds, leaving in small vas-
eline wicks for drainage. This has resulted in quicker
healing and in better scars. He has also used various
chemicals in the wounds, and, at the American College of
Surgeons in St. Louis in 1932, he showed cases in which
the wounds had been almost completely closed and drained
by wicks of gauze impregnated with merthiolate ointment.
A review of these experiments indicated that neither the
merthiolate ointment nor any other of the antiseptics used
was any more effective than plain vaseline.
In 1941, Dickson, Diveley, and Kiene reported a series
of twenty-two cases of chronic osteomyelitis in which the
infected soft tissue and bone had been meticulously
excised, the wound dusted with sulfathiazole powder and
closed in layers, and the extremity immobilized in a plaster
cast. The patients were given sulfathiazole by mouth for
five days before the operation and for about fifteen days
after the operation. Healing by primary intention occurred
in 82 per cent. of the patients.
The author began using their method in 1940, after Dr.
Dickson told him of their first success, and he has used it in
operating upon 101 consecutive patients with chronic
pyogenic infection of bone. Four patients were operated
upon twice, two were operated upon three times, and one
was operated upon four times. Of the 101 patients, the
infection was in the tibia in thirty-three, in the femur in
twenty-four, and in other bones in forty-four. In four
patients, at the first operation, an acute abscess of an old
chronic osteomyelitis was incised and drained, and no
attempt was made to close the wound. In one of these,
amputation became necessary later, and in the others
healing has now taken place. The remaining ninety-seven
patients were all operated upon while the disease was rel-
atively quiescent,—that is, the patient was afebrile, and
there were no general toxic symptoms and no evidence of
acute infection in the local lesion. In these patients, an
attempt was made to close the wound at the primary
operation. This was not always possible, because of lack of
soft tissue to cover the bone.
The technique followed was similar to that used by
Dickson, Diveley, and Kiene, except that the excision of
the infected scar tissue and sinuses was not carried out so
meticulously, and, in several instances, extensive subfas-
cial and deep abscesses were curetted and collapsed rather
than excised. The usual saucerization operation was per-
formed on the abscess cavities in the bone, and an effort
was made to remove all sequestra and to eliminate dead
spaces. However, no effort was made to remove all ebur-
nated bone, which we believe is chronically infected and
may contain minute abscess cavities which are not visible
in the roentgenogram. As few vessels as possible were
ligated, and these with fine silk, and no deep sutures were
used. The skin and subcutaneous tissue were closed in one
Fig. 1 Medium-sized cavity, with sequestrum and sinus, was excised
after eighteen months. Healing by primary intention followed closure.
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layer, usually with a continuous suture of silkworm gut,
after the wound had been sprinkled liberally with sulfat-
hiazole powder. Then a pressure dressing was applied, and
usually the limb was immobilized in a plaster cast.
Stainless-steel wire or screws were used in four instan-
ces, and in each instance the wound healed; hut later a
small sinus developed, and the offending wire or screws
were removed.
In reviewing the results obtained in these patients, it is
evident that each chronic pyogenic lesion in bone presents
an individual problem which must be solved by surgical
principles, and cannot be solved by chemotherapy. On the
other hand, the use of chemotherapy has considerably
increased the safety of our surgical procedures and has
enabled us to close a large percentage of the wounds after a
radical operation for the cure of chronic bone infection.
In this connection, it is well to consider the dangers of
chemotherapy. In this series, the adult patients were given
sulfathiazole in doses of from one gram every six hours to
one gram every four hours on the day before the operation
or earlier, and this n-as continued for about a week after the
operation. Children were given the drug in smaller doses
according to their body weight. In addition, from two to
five or even more grams of the drug was placed in the
wound before it was sutured. Routine blood levels of the
drug were not determined, but the fluid intake and output
were watched, and fluids were forced to a moderate degree.
One patient with severe renal damage was not given the
drug by mouth because he could not tolerate it. However,
about five grams of sulfathiazole was sprinkled in the
wound when his hip was disarticulated, and he made an
uneventful recovery. The generalized oedema subsided
promptly, and his condition improved after the infected
femur had been removed.
Other than postoperative fever, which may or may not
have been due to the drug and which in no instance was
alarming, toxic reactions occurred in only six patients.
These included suppression of urine in one, hematuria in
one, and skin rashes in four. All subsided promptly when
the drug by mouth was stopped and fluids were forced. It is
believed that these were due to the drug administered by
mouth, because in over 600 consecutive clean operations in
which sulfanilamide or sulfathiazole powder or a mixture
of the two drugs was implanted in the wounds there were
no toxic reactions other than fever, and only two mild
infections following operation (one from a lymph accu-
mulation and one from a hematoma).
In only one instance in this series was it necessary to
open the wound on account of an abscess after the opera-
tion. This was in an arthrodesis of an old tuberculous hip
which was secondarily infected. Bony union was obtained,
but the sinuses are still draining. In two other cases in this
series, tuberculosis was present and was complicated by
severe pyogenic infection. One knee with extensive
abscesses in the popliteal space and posterior thigh was
fused, and the sinuses were healed when the cast was
removed twelve weeks after the operation. In the other
case, the disease involved the first metacarpal and adjacent
areas of the hand and wrist. Extensive excision, with
amputation of the thumb and partial closure, resulted in a
granulating wound which is healing slowly. It has been the
author’s experience that the sulfonamides have no influ-
ence upon tuberculous infection, but they are useful in a
mixed infection.
There was one death in the series. This patient was a
woman, eighty-seven years old, who had fractured a hip
about a year before. The hip had been nailed, but the head
of the femur was dead, the neck had been absorbed, and the
distal fragment had slipped up on the nail. She returned to
the Hospital with an ulcer and abscess over the projecting
head of the nail, the infection extending into the hip joint.
The nail and dead head were removed, but the patient
gradually became weaker and died about two weeks later.
The series includes eleven amputations of one lower
extremity; all were in adults, with infection so extensive
that excision was considered impractical, as the patient
would be left with a foot and ankle which were worthless
Fig. 2 Excision of third metatarsal shaft and part of tarsal bones,
after three months, was followed by primary healing.
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from a functional standpoint. Five had non-union, and two
had old compound fractures at the ankle with extensive
chronic infection. The author performed astragalectomies
on these two and they did very well after the operation.
However, when the casts were removed, it was obvious
that amputation was necessary, and this was done without
wasting any more time. In all of the amputations, the
wounds were closed without drainage, and healed by pri-
mary intention.
Including the eleven amputations, sixty of the wounds
healed by primary intention, but sinuses later developed in
four of those which contained metal, and the metal had to
be removed. Amputation was necessary in one of these
cases; while in the other three healing occurred. In almost
all of the other cases healing has taken place. The tuber-
culous hip is still draining after one year, and a femur with
a large dead space is still draining after six months.
Another femur in which amputation was advised is still
draining, and infected bone surrounded by extensive scar
tissue is exposed on two tibiae.
All of the failures have been in adults. This is largely
because children’s bones have more regenerative capacity
than do adult bones, and it is possible to perform a more
radical operation for a given area of infection and still
obtain a useful extremity. Also, in children, if the main
focus is fairly well excised, the adjacent bone which is
mildly infected will frequently heal, and dead bone which
is not sequestrated will be absorbed and replaced by living
bone through creeping replacement. This is especially true
in young children and in cancellous bone.
It is evident that the percentage of primary healing in
this series is less than that obtained by Dickson, Diveley,
and Kiene. However, their series apparently represents a
selected group of cases in which it was possible to perform
a satisfactory excision of the focus and then close the
wound. The author’s series represents every case of chronic
bone infection that he has operated upon in the past two
and one-half years,—and he has operated upon every
patient who applied for treatment and did not refuse the
operation. This series includes three patients who refused
amputation. One of these is still disabled, one returned a
year later and died of uraemia a few days after admission,
and one has not returned. We are probably too slow in
advising amputation in these old incurable infections pf the
bones of the lower extremities in adults.
The question arises, does the method of Dickson,
Diveley, and Kiene for the treatment of chronic osteomy-
elitis have any advantage over the Orr method, which the
Fig. 3 Sequestrum and medium-sized cavity, present for ten
years, were treated by excision and closure. Healing was by
primary intention.
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author believes is the next best method? It does, because, in
about 40 per cent. of the cases, the wounds may be closed
and will heal by primary intention, if a satisfactory oper-
ation is performed. In adults, about 15 per cent. of the
affected lower extremities should be amputated; the stumps
may then be closed without drainage and will heal. In about
10 per cent., the patient will appear during an acute
exacerbation of the infection; this can be relieved by
Fig. 4A–B (A) Showing large and medium-
sized cavities with sinuses of seven years
duration. (B) Healing was by primary
intention after excision and closure.
Fig. 5A–B (A) Old compound
fracture with severe infection
of one year’s duration. (B)
Astragalectomy with closure
failed, and amputation was
necessary.
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sulfathiazole and drainage, and a radical operation which
can be done later, if necessary. In the remaining 35 per
cent. of the cases, most wounds may be almost completely
closed and will heal within a few weeks or months. There
will be a few instances, probably 10 per cent., where
amputation is not advisable and where healing does not
follow surgery plus chemotherapy. We are anxious to know
whether or nor penicillin will solve the problem presented
by these.
It is probable that most of the cases which can be cured
by the method of excision and primary closure can also be
cured by the Orr method, but only after a longer interval
and considerable unpleasantness. On the other hand, the
closed method with chemotherapy is not dangerous and
enables the surgeon to swing flaps, cover bones, and
eliminate large areas of scarring in a manner which is not
possible by any other method with which the author is
familiar. The fact should be emphasized that this method is
elastic and should be used in all cases of chronic pyogenic
infection of bone, because a failure to obtain a complete
success still represents an advance over older forms of
treatment. This advance is measured by the degree of
closure obtained and the consequent reduction in the area
which must be covered by secondary healing. If acute
infection is present and the bacteria are actively invading
the tissues, the sulfathiazole should be used locally and
systemically, and the focus should be drained. A radical
operation with excision and closure can be done at a later
date if necessary.
Discussion
DR. H. W. ORR, LINCOLN, NEBRASKA: Dr. Key says that the
wounds in this War are being treated better because we are
substituting sulfa drugs for Dakin’s solution. Dr. Key has
shown that patients have recovered after sulfa drugs by
some such equation as this: an infected wound plus
drainage plus sulfa drugs plus something else—and you get
a recovery. What Dr. Key has shown this morning, and
more nearly so than ever before, is what the patient does
toward his own recovery. He has apparently not observed
that this same program, with the sulfa drugs left out, will
give us a high percentage of recoveries even if they take
Fig. 6A–B (A) Compound, comminuted fracture with
infection and comminution of seven months’ duration. (B)
Excision and closure, with bone graft and multiple drilling,
were followed by primary healing. Wound is now healed and
fracture is united.
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longer. It has been my feeling for a long time that, while a
percentage of wounds may be closed primarily, another
large percentage cannot be closed primarily and safely
without risk to the patient. Many patients have recovered
without credit to the doctor. The patient often has some-
thing in his system that allows closure without infection.
What the sulfa drugs have to do with it, we do not know.
We may continue to hope that some drug will be found
sometime that will kill the staphylococcus without harm to
the patient.
One of the questions I was asked to answer is: What are
we to do about the odor in soiled dressings? My answer is
that soiled dressings, or dressings with a ‘‘stench’’, represent
the same thing in a dressing that infection does in a wound.
It reflects a certain degree of discredit upon the surgeon. It
has been our policy for a long time to dress these wounds
with rather voluminous sterile dressings and with padding
under the cast because we depend upon the pins embedded
in the cast for immobilization. If moisture leaks through the
sterile portion of a dressing to any outward surface which is
not sterile, you have a culture medium extending all the way
from the surface down to the wound. This is a fine field for
the development not only of staphylococci or other infec-
tion, but for saprophytes that produce odor in the dressings.
Prevention of contamination makes for prevention of
infection and odor. If we prepare the wound and the cast so
that no secretion exudes to the outside, odor will be pre-
vented. That cannot be done at all times, but with a
sufficiently sterile dressing, and with adequate disinfection
chemically at the time of operation, the patient can be
protected against that sort of thing. If complications occur in
a wound, the surgeon will know how to protect the wound.
If complications do occur, we may use heat about the
wound area, just as we use heat for the wound itself.
DR. FRANK D. DICKSON, KANSAS CITY, MISSOURI: I am
particularly pleased to discuss Dr. Key’s paper, because our
own interest in the local use of sulfonamides in osteomy-
elitis was stimulated by one of Dr. Key’s original
communications on the local use of these drugs. I would
like to discuss this paper in an abstract way, avoiding
controversial comparisons.
Dr. Key called attention to the fact that, if sulfonamides
are going to be of value in local infection, three factors are
important: first, the concentration of the drug in the
immediate environment of the bacteria to be acted upon;
second, the degree of concentration of sulfonamide-inhib-
itor substances present; and third, the effectiveness of the
natural defense mechanism of the body. All investigation
seems to indicate that a higher degree of concentration of
the drug in the immediate environment of the bacteria is
secured by the use of the sulfonamides locally than can
be obtained by any known safe method of systemic
administration. This strongly suggests that, if the
sulfonamides have any value, their local use is the most
effective method of utilizing them. However, it is equally
true that no matter how high a concentration of the drug is
present in the environment of the bacteria, unless the
introduction of the sulfonamides has been preceded by a
thorough surgical clean-up of both bone and soft parts to
eliminate or reduce to a minimum the sulfonamide-inhib-
itor substances (pus and necrotic tissue), you are not going
to get results, since their action will be nullified. In other
words, the primary factor of success is adequate surgery.
What does an adequate clean-up do when you are
dealing with an osteomyelitic focus? It should do two
things. First, it should reduce to a minimum the sulfon-
amide-inhibitor substances by removal of the source of
these substances, which is pus and debris in the wound.
Second, it should mechanically remove large quantities of
bacteria. When these two purposes have been accom-
plished, the sulfonamides should be able to take care of
what remains in the way of infecting bacteria, by inhibiting
their growth, and to allow healing to take place by normal
tissue repair.
As to primary closure, I am glad Dr. Key emphasized this
fact, which we tried to emphasize when we originally
reported our cases. If you are going to close a wound pri-
marily, you must dissect away all scar tissue so as to bring
the denuded bone into contact with healthy tissue with a
good blood supply. I am convinced that bringing sclerotic
scar tissue into contact with denuded bone is unphysiolog-
ical. Certainly, its blood supply is poor and its lack of
plasticity does not permit it to lie in close contact with the
bone and so eliminate dead space, which is one of the pri-
mary factors in securing healing. So Dr. Key was quite right
when he emphasized that this method of treatment was not
advisable unless you could bring about a satisfactory clo-
sure. In about 80 per cent. of our cases of subacute and
chronic osteomyelitis, in which the sulfonamides were used
locally and systemically and primary closure was carried
out, primary healing took place within three to four weeks. I
believe our failures in the other 20 per cent. have been due
to a poor selection of cases,—that is, we selected cases in
which we were not able to get the proper tissue to cover the
denuded bone. In but three or four of the failures has there
been any extensive breaking down. There is usually a small
area which does not heal, suggesting the existence of a dead
space. If this method has any advantages, and we feel it has,
there are two. In the first place, it gives rapid healing in
three to four weeks. In the second, healing occurs with a
minimum of scar-tissue formation. This is a very definite
advantage if future reconstructive work is to be carried on.
We have found it particularly useful in infected compound
fractures, since the absence of extensive scar tissue enables
us safely to apply a bone graft in eight to twelve weeks
following healing.
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DR. J. ALBERT KEY, ST. LOUIS, MISSOURI (closing): I did
not realize that I had given the impression that the patient
did not have something to do with healing. Sulfonamides
do nothing but inhibit the growth of bacteria. By so doing,
the wounds can be closed with a good margin of safety,
99+ per cent. In 101 cases we had only one abscess that
required opening. However, some wounds could not be
closed completely and from others there was drainage
between the sutures.
I think that Dr. Dickson is wrong when he says that a
meticulous operation is necessary. On several occasions
where there were deep abscesses extending up beneath the
fascia, I simply curetted them, wiped them out with gauze,
removed most of the infection, put in sulfanilamide pow-
der, and immobilized the limb under a pressure dressing in
a plaster cast. We used this method in every case, but were
not always able to do a complete operation. It is a great
advance over what we were able to do before the advent of
the sulfonamides.
With his method, Dr. Orr may be able to keep the
wounds dry, but I cannot. I do not like pin fixation with
the Orr treatment, because pus may develop around the
pin, and sometimes this leads to a diffuse infection of the
bone.
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